New active substances that are suitable for drugs are initially tested in animal experiments. However, the results cannot always be transferred to the human organism. At the Karlsruhe Institute of Technology, Prof. Ute Schepers from vasQlab explains how active substances can be tested in human tissue without endangering human health.
According to WHO, about 251 million people worldwide had Chronic Obstructive Pumonary Disease in 2016. COPD denotes not a single, but several diseases that are caused by smoking and air pollution, among others. Patients at a later disease stage often need ventilation and are thus bound to the location of their devices. We visited the Aachen-based start-up enmodes to learn how the RAS-Q technology could make COPD patients mobile again.